Artal Group’s AC Immune ACIU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,000,000
| Closed | -$2.04M | – | 119 |
|
|
2022
Q4 | $2.04M | Hold |
1,000,000
| – | – | 0.11% | 84 |
|
|
2022
Q3 | $3.16M | Hold |
1,000,000
| – | – | 0.13% | 74 |
|
|
2022
Q2 | $3.61M | Hold |
1,000,000
| – | – | 0.19% | 71 |
|
|
2022
Q1 | $4M | Hold |
1,000,000
| – | – | 0.17% | 88 |
|
|
2021
Q4 | $4.95M | Hold |
1,000,000
| – | – | 0.13% | 98 |
|
|
2021
Q3 | $6.71M | Hold |
1,000,000
| – | – | 0.15% | 94 |
|
|
2021
Q2 | $7.93M | Hold |
1,000,000
| – | – | 0.16% | 94 |
|
|
2021
Q1 | $7.61M | Hold |
1,000,000
| – | – | 0.13% | 99 |
|
|
2020
Q4 | $5.17M | Hold |
1,000,000
| – | – | 0.11% | 98 |
|
|
2020
Q3 | $4.88M | Buy |
1,000,000
+15,450
| +2% | +$75.4K | 0.12% | 86 |
|
|
2020
Q2 | $6.63M | Sell |
984,550
-15,450
| -2% | -$104K | 0.19% | 76 |
|
|
2020
Q1 | $6.91M | Hold |
1,000,000
| – | – | 0.29% | 51 |
|
|
2019
Q4 | $8.52M | Hold |
1,000,000
| – | – | 0.33% | 47 |
|
|
2019
Q3 | $4.95M | Hold |
1,000,000
| – | – | 0.2% | 63 |
|
|
2019
Q2 | $5.55M | Hold |
1,000,000
| – | – | 0.22% | 63 |
|
|
2019
Q1 | $5.05M | Buy |
1,000,000
+250,000
| +33% | +$1.26M | 0.21% | 60 |
|
|
2018
Q4 | $7.09M | Hold |
750,000
| – | – | 0.26% | 38 |
|
|
2018
Q3 | $6M | Buy |
750,000
+150,000
| +25% | +$1.2M | 0.16% | 48 |
|
|
2018
Q2 | $5.59M | Hold |
600,000
| – | – | 0.12% | 45 |
|
|
2018
Q1 | $6.2M | Buy |
600,000
+100,000
| +20% | +$1.03M | 0.08% | 37 |
|
|
2017
Q4 | $6.4M | Hold |
500,000
| – | – | 0.1% | 31 |
|
|
2017
Q3 | $5.59M | Hold |
500,000
| – | – | 0.1% | 33 |
|
|
2017
Q2 | $4.4M | Hold |
500,000
| – | – | 0.08% | 44 |
|
|
2017
Q1 | $5.18M | Buy |
500,000
+250,000
| +100% | +$2.59M | 0.12% | 39 |
|
|
2016
Q4 | $3.25M | Buy |
250,000
+100,000
| +67% | +$1.3M | 0.07% | 40 |
|
|
2016
Q3 | $2.47M | Buy |
+150,000
| New | +$2.47M | 0.05% | 54 |
|